A Study of AZD8233 in Participants With Dyslipidemia
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.
Also called NCT04641299
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 119 participants
- Sponsor
- Registry
-
NCT04641299
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Denmark, Slovakia
- Registry status
- Completed
Technical summary
Registry record NCT04641299. Randomized; quadruple masking; primary purpose treatment. Start 2020-10-28 (actual); primary completion 2021-07-20 (actual). Results posted on 2022-11-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of AZD8233 in Participants With Dyslipidemia
- Condition
- Dyslipidaemia
- Intervention (Drug)
- AZD8233
- Intervention (Drug)
- Placebo
- Lead sponsor
- AstraZeneca
Record details
- Record id
cardio:ct-nct04641299- Content hash
8844db0c5284c1fe73b36c22a5eab11fc088dd164952683b00f30dd17eb2bedf